Published in Vasc Med on November 01, 2004
Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence. Br J Gen Pract (2011) 1.49
Exercise therapy for claudication: latest advances. Curr Treat Options Cardiovasc Med (2013) 0.82
Community walking programs for treatment of peripheral artery disease. J Vasc Surg (2013) 0.81
Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease. Cardiovasc Revasc Med (2015) 0.78
Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation. J Vasc Surg (2007) 0.76
Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. J Am Heart Assoc (2014) 0.75
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation (2007) 2.63
Improving Diabetes Care in Practice: findings from the TRANSLATE trial. Diabetes Care (2008) 2.42
Exercise training for claudication. N Engl J Med (2002) 2.26
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke (2004) 2.24
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J (2008) 2.09
Treatment of peripheral arterial disease--extending "intervention" to "therapeutic choice". N Engl J Med (2006) 1.98
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA (2010) 1.97
Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation (2011) 1.97
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J (2009) 1.84
Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med (2005) 1.81
Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation (2013) 1.73
Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation (2004) 1.59
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol (2010) 1.59
Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med (2004) 1.57
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial. J Am Coll Cardiol (2003) 1.54
Comparison of health-related quality-of-life outcomes of men and women after coronary artery bypass surgery through 1 year: findings from the POST CABG Biobehavioral Study. Am Heart J (2003) 1.53
Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol (2007) 1.53
A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. J Am Coll Cardiol (2008) 1.50
Descending aortic diameter of 5.5 cm or greater is not an accurate predictor of acute type B aortic dissection. J Thorac Cardiovasc Surg (2011) 1.49
A proposed coast-wide reference monitoring system for evaluating wetland restoration trajectories in Louisiana. Environ Monit Assess (2003) 1.45
Cost-effectiveness analysis of protected carotid artery stent placement versus endarterectomy in high-risk patients. J Endovasc Ther (2010) 1.45
The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J (2006) 1.45
Claudication: exercise vs endoluminal revascularization (CLEVER) study update. J Vasc Surg (2009) 1.43
Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol (2010) 1.41
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes (2010) 1.39
The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med (2008) 1.37
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.36
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol (2002) 1.30
Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc (2005) 1.26
Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol (2009) 1.23
The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg (2008) 1.22
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (2005) 1.21
One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes (2008) 1.21
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med (2002) 1.19
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation (2012) 1.19
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med (2011) 1.19
Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health (2009) 1.18
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis (2008) 1.16
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol (2010) 1.13
Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med (2010) 1.13
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol (2009) 1.11
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2012) 1.09
Functional outcomes and quality of life in peripheral arterial disease: current status. Vasc Med (2003) 1.07
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis (2011) 1.07
A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nurs Scholarsh (2002) 1.06
Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (2006) 1.04
Multidisciplinary standardized care for acute aortic dissection: design and initial outcomes of a regional care model. Circ Cardiovasc Qual Outcomes (2010) 1.03
An international model to predict recurrent cardiovascular disease. Am J Med (2012) 1.02
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J (2008) 1.02
Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis (2012) 1.02
Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study. Vasc Med (2009) 1.01
The cost-effectiveness of anorexia nervosa treatment. Int J Eat Disord (2004) 1.01
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg (2008) 1.01
What factors influence participation in an exercise-focused, employer-based wellness program? Inquiry (2011) 1.00
Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>-2.5 for alendronate therapy: a modeling study. J Clin Densitom (2006) 0.99
Peripheral arterial disease rehabilitation: a review. J Cardiopulm Rehabil (2003) 0.97
Discectomy strategies for lumbar disc herniation: results of the LAPDOG trial. J Clin Neurosci (2002) 0.96
Effect of direct mail as a population-based strategy to increase mammography use among low-income underinsured women ages 40 to 64 years. Cancer Epidemiol Biomarkers Prev (2005) 0.95
Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy. Osteoporos Int (2005) 0.95
Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? Circulation (2008) 0.95
Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis (2008) 0.95
A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res (2010) 0.94
Carotid intima-media thickness testing by non-sonographer clinicians: the office practice assessment of carotid atherosclerosis study. J Am Soc Echocardiogr (2007) 0.92
Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy. Circulation (2004) 0.92
International heterogeneity in diagnostic frequency and clinical outcomes of ascending aortic intramural hematoma. J Am Soc Echocardiogr (2007) 0.91
Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study. Vasc Med (2005) 0.91
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.91
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.90
Ultrasound detection of increased carotid intima-media thickness and carotid plaque in an office practice setting: does it affect physician behavior or patient motivation? J Am Soc Echocardiogr (2008) 0.90
Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis (2008) 0.89
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease. Vasc Med (2010) 0.89
Use of time studies for determining intervention costs. Nurs Res (2005) 0.88
A health economic analysis of clinical islet transplantation. Clin Transplant (2011) 0.87
Postgraduate training in vascular medicine: proposed requirements and standards. Vasc Med (2003) 0.87
Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes. Atherosclerosis (2012) 0.87
Correlates of caregiver burden after coronary artery bypass surgery. Nurs Res (2006) 0.87